Skip to main content
Clinical Trials/NCT05112341
NCT05112341
Unknown
Not Applicable

Adjuvant Whole Breast Irradiation in Five Fractions Versus Fifteen Fractions in Early Breast Cancer

Sohag University1 site in 1 country50 target enrollmentJune 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Study on Breast Cancer Patients
Sponsor
Sohag University
Enrollment
50
Locations
1
Primary Endpoint
1-disease free survival
Last Updated
4 years ago

Overview

Brief Summary

the study aiming for compairing results of hypofractionaton radiotherapy treatment in patient with early breast cancer between two arms the first arm recieving five fractions and the other arm recieving fifteen fraction

Registry
clinicaltrials.gov
Start Date
June 1, 2021
End Date
October 1, 2023
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Heba Ali Elsagheer

assistant lecturer of oncolgy. sohag university hospital

Sohag University

Eligibility Criteria

Inclusion Criteria

  • age group ( 18-80) years
  • breast conservation surgery
  • Stages (pT1-3, pN0-1, M0) breast cancer.
  • Any histological type of invasive breast cancer.
  • All grades of breast cancer (I,II,III)

Exclusion Criteria

  • Stage (III or IV) breast cancer.
  • Metastatic breast cancer (MBC)
  • Recurrent breast cancer.
  • Patients' co-morbidities that contraindicate radiotherapy

Outcomes

Primary Outcomes

1-disease free survival

Time Frame: 2 years

the time free from disease

3- toxicity from treatment

Time Frame: 2 years

side effects from treatment

2- overall survival

Time Frame: 2 years

the period time from treatment till death

Study Sites (1)

Loading locations...

Similar Trials